[1] |
顾晋. 腹腔镜直肠癌外科临床诊治中的问题与对策[J/CD].中华普外科手术学杂志(电子版),2022, 16(01): 9-12.
|
[2] |
Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes[J]. Curr Drug Targets, 2021, 22(9): 998-1009.
|
[3] |
Patel SG, Karlitz JJ, Yen T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology,clinical features, biology, risk factors, prevention, and early detection [J]. Lancet Gastroenterol Hepatol, 2022, 7(3): 262-274.
|
[4] |
Song M, Liu Z, Wu F, et al. Serum tumor marker and CT body composition scoring system predicts outcomes in colorectal cancer surgical patients. Eur Radiol, 2024, 34(12): 7596-7608.
|
[5] |
Abedizadeh R, Majidi F, Khorasani HR, et al. Colorectal cancer:a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments [J]. Cancer Metastasis Rev,2024, 43(2): 729-753.
|
[6] |
徐一栋,俞甲子,张佳健,等. 结直肠癌肝转移瘤切除术后早期肝内复发相关因素分析和预测模型构建[J]. 癌症,2024,43(02): 76-87.
|
[7] |
Hasselager RP, Hallas J, Gögenur I. Epidural Analgesia and Recurrence after Colorectal Cancer Surgery: A Danish Retrospective Registry-based Cohort Study [J]. Anesthesiology,2022, 136(3): 459-471.
|
[8] |
Wu Y, Zhang S, Yan J. IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence [J]. Oncol Lett, 2020, 19(3): 1759-1770.
|
[9] |
陈瀚玮,李磊. 结直肠癌肝转移肝切除术后不同复发模式的预后差异及危险因素分析[J/CD]. 肝癌电子杂志,2024,11(02): 27-32.
|
[10] |
Försti A, Ambrozkiewicz F, Marciniak M, et al. Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers [J]. Int J Cancer, 2025,156(7): 1393-1403.
|
[11] |
Suzuki Y, Ogura A, Uehara K, et al. The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer [J]. Int J Clin Oncol, 2021, 26(7): 1264-1271.
|
[12] |
Pian G, Shin JS, Yoon S, et al. Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer [J]. Anticancer Res, 2021, 41(2): 1101-1110.
|
[13] |
石彦科,颜廷启,孙伟涛,等. 血清CXCL12及其受体CXCR4、CXCR7与结肠癌患者临床病理特征及术后肝转移的关系研究[J]. 检验医学与临床,2025, 22(02): 178-183, 189.
|
[14] |
魏丕喜,赵彩玲,唐思锋,等. 微小RNA-183、微小RNA-26a对结肠癌的诊断价值及与结肠癌预后的关系[J]. 中华实验外科杂志,2024, 41(09): 2074-2077.
|
[15] |
张成熙,李启刚. 围术期CEA及CA19-9检测水平对结直肠癌术前分期及术后预后的影响[J]. 检验医学与临床,2018,15(24): 3698-3701, 3706.
|
[16] |
Gao Y, Wang J, Zhou Y, Sheng S, et al. Evaluation of Serum CEA,CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer[J]. Sci Rep,2018, 8(1): 2732.
|
[17] |
Huang H, Huang J, Huang W, et al. Clinical Observation and Analysis of Transient Postoperative CA-125 Elevation in a Patient with Sigmoid Colon Adenocarcinoma [J]. Clin Lab, 2025, 71(2):21-29.
|
[18] |
朱磊,赵阳,韩仕峰,等. 术前血清CEA和CA19-9水平检测对结肠癌术后早期复发转移的预测价值[J]. 中国普通外科杂志,2015, 24(08): 1170-1174.
|
[19] |
Han B, Hu H, Zhang J, et al. Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer [J].Br J Hosp Med (Lond), 2025, 86(2): 1-18.
|
[20] |
曹鑫,丁杨青,徐玉凤,等. Ⅲ期结肠癌患者根治术后复发的影响因素分析[J]. 实用癌症杂志,2022, 37(11): 1820-1822.
|
[21] |
Mizuno H, Miyake H, Nagai H,et al. Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/Ⅲ colon cancer [J]. Langenbecks Arch Surg, 2021, 406(6): 1987-1997.
|
[22] |
Mazaki J, Tsukamoto S, Miyake M, et al. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy [J]. Dis Colon Rectum, 2021, 64(1): 71-80.
|
[23] |
O'Brien SJ, Scheurlen K, Rochet A, et al. Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence [J]. J Surg Res, 2022, 269: 59-68.
|
[24] |
Otani T, Kanemura H, Kimura M, et al. Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report [J]. Int J Surg Pathol,2022, 30(6): 646-651.
|